We are live on ! Find out more
SCP

Sender Company & Partners Portfolio holdings

AUM $165M
1-Year Est. Return 34.66%
This Fund
S&P 500
This Quarter Est. Return
-4.78%
1 Year Est. Return
+34.66%
3 Year Est. Return
+36.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$212M
Cap. Flow %
108.36%
Top 10 Hldgs %
41.58%
Holding
95
New
95
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$9.82M
2
MQ icon
Marqeta
MQ
+$8.05M
3
F icon
Ford
F
+$7.49M
4
GM icon
General Motors
GM
+$6.66M
5
VMEO
Vimeo
VMEO
+$5.95M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 24.87%
2 Consumer Discretionary 17.18%
3 Communication Services 14.64%
4 Industrials 4.06%
5 Healthcare 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
76
Aclaris Therapeutics
ACRS
$772M
$438K 0.22%
+30,132
New +$457K
AVEO
77
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$432K 0.22%
+92,026
New +$571K
COGT icon
78
Cogent Biosciences
COGT
$6.64B
$419K 0.21%
+48,861
New +$425K
RNG icon
79
CALL
RingCentral
RNG
$4.81B
$412K 0.21%
+2,200
New +$488K
RZLT icon
80
Rezolute
RZLT
$479M
$391K 0.2%
+81,849
New +$478K
XENE icon
81
Xenon Pharmaceuticals
XENE
$6.02B
$382K 0.2%
+12,215
New +$365K
AMD icon
82
CALL
Advanced Micro Devices
AMD
$846B
$345K 0.18%
+2,400
New +$323K
KURA icon
83
Kura Oncology
KURA
$816M
$285K 0.15%
+20,359
New +$330K
TWTR
84
CALL
DELISTED
Twitter, Inc.
TWTR
$281K 0.14%
+6,500
New +$338K
VRDN icon
85
Viridian Therapeutics
VRDN
$2.13B
$242K 0.12%
+12,216
New +$228K
RVLV icon
86
Revolve Group
RVLV
$1.86B
$228K 0.12%
+4,072
New +$286K
NET icon
87
Cloudflare
NET
$100B
$214K 0.11%
+1,629
New +$273K
TSLA icon
88
CALL
Tesla
TSLA
$1.29T
$211K 0.11%
+600
New +$201K
CBAY
89
DELISTED
Cymabay Therapeutics
CBAY
$206K 0.11%
+61,080
New +$232K
DNMR
90
DELISTED
Danimer Scientific, Inc.
DNMR
$194K 0.1%
+570
New +$314K
TARA icon
91
Protara Therapeutics
TARA
$223M
$192K 0.1%
+28,502
New +$197K
CTMX icon
92
CytomX Therapeutics
CTMX
$690M
$176K 0.09%
+40,720
New +$239K
TALK icon
93
Talkspace
TALK
$873M
$160K 0.08%
+81,440
New +$233K
ACHL
94
DELISTED
Achilles Therapeutics
ACHL
$139K 0.07%
+27,690
New +$168K
HARP
95
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$108K 0.06%
+1,425
New +$97.2K
1 2 3
4

Similar funds

BCA
Bitterroot Capital Advisors Bozeman, Montana $165M AUM
OCM
Occam Crest Management Darien, Connecticut $165M AUM
CPL
Capital & Planning LLC Jonesboro, Georgia $165M AUM 27.22% 1-Year Est. Return
BPMC
Buckland Partners Management Co Harrison, New York $165M AUM
CCM
Clutterbuck Capital Management Cleveland, Ohio $164M AUM
COA
Charter Oak Advisors New York City, New York $165M AUM 86.5% 1-Year Est. Return
GAAM
Grand Alliance Asset Management Central, Hong Kong $165M AUM 359.07% 1-Year Est. Return
GC
Gould Capital Tacoma, Washington $165M AUM 19.29% 1-Year Est. Return

Sender Company & Partners's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Sender Company & Partners, which disclosed 95 positions worth $195M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is State Street SPDR S&P Biotech ETF: 81,441 shares worth $9.12M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Consumer Discretionary and Communication Services.

  • Sender Company & Partners's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 81,441 shares worth $9.12M.
  • Sender Company & Partners's ten largest holdings make up 42% of its $195M portfolio in Q4 2021.
  • Sender Company & Partners disclosed 95 positions in Q4 2021, its first 13F filing on record.

Based on Sender Company & Partners's 13F filing for Q4 2021, filed 14 Feb 2022.